rcrsd

Mutual Pharmaceutical Company v. Bartlett: How the Decision Affects Us

In our previous blog post, we discussed the Supreme Court decision to prevent consumers from seeking legal recourse for injuries caused by defective generic drugs under preemption laws. The decision favors manufacturers and is conceptually in conflict with the 2009 Supreme Court ruling that brand-name manufacturers may be sued for damages caused by drug defects….

read more

U.S. Drug Watchdog Urges Metal-on-Metal Hip Implant Recipients to Get Blood Tests

The U.S. Drug Watchdog is a consumer advocate for victims of defective medical devices and recalled drugs in the United States. The group considers the metal-on-metal hip replacement situation the largest medical device failure in U.S. history. Additionally, the group predicts that hundreds of thousands of metal-on-metal hip implant recipients will experience or have already…

read more

Impact of the Physician Payment Sunshine Act on State Regulations: Disclosure Laws

The Patient Protection and Affordable Care Act of 2010 includes, among its provisions, the Physician Payment Sunshine Act (PPSA), which generally requires that pharmaceutical companies disclose payments to physicians for the marketing of their products. It is the first Congressional effort in the regulation of disclosure-related pharmaceutical marketing. The PPSA took effect in January 2012,…

read more

L.A. Civil Court Budget Cuts: Changing Trial Times and Staff

In addition to proposed Los Angeles County trial location changes, pending budget cuts will, if approved, range from $56 to 85 million dollars, and negatively impact multiple other aspects of the legal system. The law firm of Robinson Calcagnie Robinson Shapiro Davis, Inc. is against the cuts due to the limitations they will impose on…

read more

Government Website Created for Physician Sunshine Act

For years, the pharmaceutical industry has targeted physicians and teaching hospitals to help them market their products. Drug companies provide free samples of their product for physician’s to use and offer lucrative opportunities for those who promote their drug, including gifts, dining and entertainment, lecturing opportunities in resort destinations and other forms of payment. This…

read more